Early neovascular bridging after photodynamic therapy of myopic choroidal neovascularization

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 242, Issue 10, 2004, Pages 840-844

  Lanzetta, Paolo ^a   Battaglia Parodi, Maurizio ^b   Ambesi Impiombato, Massimo ^a   Ravalico, Giuseppe ^b   Bandello, Francesco ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; VASCULOTROPIN;

ADULT; ARTICLE; CASE REPORT; CHOROID VASCULARIZATION; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MYOPIA; OUTCOMES RESEARCH; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA NEOVASCULARIZATION; STANDARDIZATION; TREATMENT PLANNING;

CHOROIDAL NEOVASCULARIZATION; CONTRACTURE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MIDDLE AGED; MYOPIA, DEGENERATIVE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; POSTOPERATIVE COMPLICATIONS;

EID: 8444242498     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-004-0904-0     Document Type: Article

References (12)

1. Battaglia Parodi M, Da Pozzo S, Ravalico G (2003) Angiographic features after photodynamic therapy for choroidal neovascularization in age-related macular degeneration and pathologic myopia. Br J Ophthalmol 87: 177-183
2. Haimovici R, Kramer M, Miller JW, et al (1997) Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. Curr Eye Res 16: 83-90
3. Husain D, Kramer M, Kenny AG (1999) Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci 40: 2322-2331 1:STN:280:DyaK1MvgsVCnuw%3D%3D, 10476799
4. Michels S, Schmidt-Erfurth U (2003) Sequence of vascular events following photodynamic therapy Invest Ophthalmol Vis Sci 44:2147-2154 10.1167/iovs.02-0604
5. Ohno-Matsui K, Morita I, Tombran-Tink J, et al (2001) Novel mechanism for age-related macular degeneration: An equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol 189: 323-333
6. Olsen TW, Capone A, Sternberg P, et al (1996) Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology 103: 2061-2069 1:STN:280:ByiC2MnpsF0%3D, 9003340
7. Schmidt-Erfurth U, Miller J, Sickenberg M, et al (1998) Photodynamic therapy of subfoveal choroidal neovascularization: Clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol 236: 365-374 1:STN:280:DyaK1c3msFSgsw%3D%3D, 9602321
8. Schmidt-Erfurth U, Michels S, Barbazetto I, Laqua H (2002) Photodynamic effects on choroidal neovascularizations and physiological choroid. Invest Ophthalmol Vis Sci 43:830-841 11867605
9. Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A, Naumann GO (2003) Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 44:4473-4480 10.1167/iovs.02-1115, 14507895
10. Soubrane G, Coscas G, Kuhn D (1999) Myopia. In Guyer DR, Yannuzzi LA, Chang S, Shields JA, Green WR (eds) Retina, vitreous, macula. Saunders, Philadelphia, pp 189-205
11. Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial - VIP report no. 1 (2001) Ophthalmology 108: 841-852 10.1016/S0161-6420(01)00544-9, 11320011
12. Verteporfin in Photodynamic Therapy (VIP) Study Group (2003) Verteporfin therapy in subfoveal choroidal neovascularization in pathologic myopia. 2-year results of a randomised clinical trial - VIP report no. 3. Ophthalmology 110: 667-673 10.1016/S0161-6420(02)01998-X, 12689884